Literature DB >> 8704541

Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales.

J Sheridan1, J Strang, N Barber, A Glanz.   

Abstract

OBJECTIVES: To establish activity levels of community (high street) pharmacies in the provision of HIV prevention services to drug misusers and to compare these findings with the levels identified in 1988.
DESIGN: Self completion questionnaire (four mailings) to a random 1 in 4 sample of all community pharmacies, stratified by family health services authority.
SETTING: England and Wales.
SUBJECTS: Data provided by pharmacist in charge of the dispensary, on service provision at the pharmacy. MAIN OUTCOME MEASURES: Quantitative reports of current activity levels for (a) dispensing of controlled drugs to drug misusers, (b) sale of needles and syringes, (c) needle and syringe exchange.
RESULTS: 74.8% response rate (1984/2654). In 1995, 50.1% (992/1980) of pharmacies were dispensing controlled drugs (mostly methadone), compared with 23.0% (562/2457) in 1988; 34.5% (677/1962) of pharmacies were selling injecting equipment, compared with 28.0% (676/2434) in 1988; 18.9% (366/1937) were providing a needle exchange service, compared with 3.0% (65/2415) in 1988.
CONCLUSION: Activity levels increased substantially across all three service areas. Increased activity included greater individual activity as well as higher proportions of pharmacies participating. The network of community pharmacies represents an underused point of contact for this Health of the Nation target population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704541      PMCID: PMC2351660          DOI: 10.1136/bmj.313.7052.272

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  3 in total

1.  The effect of exposure to sub-lethal doses of phosgene on the subsequent l(ct)50 for rats and mice.

Authors:  G E Box; H Cullumbine
Journal:  Br J Pharmacol Chemother       Date:  1947-03

2.  Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales.

Authors:  A Glanz; C Byrne; P Jackson
Journal:  BMJ       Date:  1989-10-28

3.  Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales.

Authors:  J Strang; J Sheridan; N Barber
Journal:  BMJ       Date:  1996-08-03
  3 in total
  18 in total

1.  Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices.

Authors:  C R Harbke; D G Fisher; H H Cagle; B N Trubatch; A M Fenaughty; M E Johnson
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

2.  Office-based methadone prescribing: acceptance by inner-city practitioners in New York.

Authors:  J McNeely; E Drucker; D Hartel; E Tuchman
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

3.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

4.  Methadone treatment for opiate addicts.

Authors:  J L Sorensen
Journal:  BMJ       Date:  1996-08-03

5.  Methadone treatment. Methadone treatment is not the only option.

Authors:  J R Robertson; J Macleod
Journal:  BMJ       Date:  1996-12-07

6.  Involvement of Sudanese community pharmacists in public health activities.

Authors:  Sumia Sir-Elkhatim Mohamed; Adil A Mahmoud; Abdulazim A Ali
Journal:  Int J Clin Pharm       Date:  2013-02-16

7.  Are postal questionnaire surveys of reported activity valid? An exploration using general practitioner management of hypertension in older people.

Authors:  M Eccles; G A Ford; S Duggan; N Steen
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

8.  Consumer attitudes about opioid addiction treatment: a focus group study in New York City.

Authors:  Nancy L Sohler; Linda Weiss; James E Egan; Carolina M López; Jamie Favaro; Robert Cordero; Chinazo O Cunningham
Journal:  J Opioid Manag       Date:  2013 Mar-Apr

9.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

10.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2009-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.